Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ReFineDR observational ophthalmology study in FIDELIO/FIGARO participants
jRCT2080225272Phase 2Completed
- Sponsor
- Bayer
- Start
- Jul 2020
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, double-blind trial in diabetic retinopathy (DR), type 2 diabetes mellitus (T2DM) and chronic kidney disease (CKD) comparing Finerenone arm with Placebo arm (2 arms). Started Jul 2020; status: completed.
02
Drugs
finerenone
03
Conditions
diabetic retinopathy (DR)type 2 diabetes mellitus (T2DM)chronic kidney disease (CKD)
Beyond the preview
Go deeper on jRCT2080225272.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080225272.